IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 127 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $129,000 | +55.4% | 4,661 | +2.2% | 0.00% | 0.0% |
| Q3 2019 | $83,000 | -25.2% | 4,561 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $111,000 | +42.3% | 4,561 | -43.8% | 0.00% | 0.0% |
| Q1 2019 | $78,000 | +8.3% | 8,118 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $72,000 | +24.1% | 8,118 | +58.6% | 0.00% | 0.0% |
| Q3 2018 | $58,000 | -47.7% | 5,118 | -41.1% | 0.00% | -50.0% |
| Q2 2018 | $111,000 | -53.6% | 8,696 | -38.6% | 0.00% | -33.3% |
| Q1 2018 | $239,000 | +1095.0% | 14,169 | +455.6% | 0.00% | – |
| Q4 2017 | $20,000 | -13.0% | 2,550 | -15.0% | 0.00% | – |
| Q3 2017 | $23,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |